Home › Funds › Two Sigma Investments › ANVS
Two Sigma Investments position in ANVS
ANNOVIS BIO INC · Health Care
Latest position (Q2 2026)579.57K sh
Reported value held$1.08M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 97.57K | $3.10M | New |
| Q4 2021 | 51.75K | $910.00K | Reduce |
| Q4 2024 | 10.92K | $54.94K | New |
| Q1 2025 | 166.22K | $249.33K | Add |
| Q1 2025 | 166.22K | $249.33K | Add |
| Q4 2025 | 551.84K | $1.91M | New |
| Q1 2026 | 627.66K | $1.40M | Add |
| Q2 2026 | 579.57K | $1.08M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ANVS
- Marshall Wace 1.84M sh · $3.43M · Q2 2026
- Vanguard Group 923.20K sh · $3.19M · Q4 2025
- Renaissance Technologies 1.00M sh · $1.86M · Q2 2026
- Geode Capital Management 283.82K sh · $528.13K · Q2 2026
- BlackRock Inc 249.86K sh · $464.73K · Q2 2026
- Citadel Advisors 114.80K sh · $213.53K · Q2 2026
- Northern Trust Corp 68.07K sh · $126.61K · Q2 2026
- Wells Fargo & Co 30.31K sh · $56.37K · Q2 2026
- Millennium Management 23.46K sh · $43.64K · Q2 2026
- BNY Mellon 15.48K sh · $28.79K · Q2 2026
- JPMorgan Chase & Co 15.22K sh · $28.31K · Q2 2026